建立一个开放的标准全面的癌症队列研究数据库
Chung-Yueh Lien1, Chao-Wei Hsu1, Pau-Choo Chung2
1Dept. of Information Management, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Studies in health technology and informatics
|August 8, 2025
概括
这项研究创建了一个癌症研究数据库,使用医疗互操作性标准,如快速医疗互操作性资源 (FHIR) 和医学数字成像和通信 (DICOM). 该框架整合了来自电子健康记录的各种数据,用于全面的癌症队列分析.
科学领域:
- 生物医学信息学 生物医学信息学
- 健康 数据科学 数据科学
- 癌症研究 信息学 信息学
背景情况:
- 医疗保健数据在多个电子健康记录 (EHR) 系统中分散.
- 整合不同类型的数据 (人口统计,成像,基因组学) 对于全面的癌症研究至关重要.
- 需要标准化的互操作性框架来促进数据聚合.
研究的目的:
- 开发一个全面的癌症队列研究数据库框架.
- 为了利用医疗保健互操作性标准 (FHIR,DICOM) 进行数据集成.
- 在多个EHR系统中实现无数据交换和分析.
主要方法:
- 开发了EHR数据的数据收集管道,包括人口统计,报告,CT图像,整个幻灯片图像 (DICOM) 和基因组数据.
- 使用国际术语 (ICD,LOINC,SNOMED CT) 将收集的数据转换为快速医疗互操作性资源 (FHIR) 格式.
- 利用FHIR成像报告实施指南,并通过cBioPortal将基因组数据集成到一个集中式门户.
主要成果:
- 成功收集和整合了来自625例非小细胞肺癌和373例头癌病例的数据.
- 建立了基于FHIR的数据结构,用于各种与癌症相关的信息.
- 实施了一个集中式门户网站,用于访问和分析综合多式模式的癌症数据.
结论:
- 开发的框架有效地整合了癌症研究的异质医疗保健数据.
- 使用FHIR和DICOM标准有助于创建强大的癌症队列数据库.
- 集中式门户网站通过数据集成为促进癌症研究提供了宝贵的资源.
相关概念视频
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer
49.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.6K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


